In NSCLC, down trending IL-2 may signal T-cell dysfunction or regulatory T-cell skewing, suggesting an immunosuppressive milieu or exhaustion phenotype, whilst in melanoma, IL-2 elevations may indicate heightened CD8+ expansion, consistent with its known immunogenicity. This evidence concerns the gene IL2 and melanoma.